Chemotherapy and Drug Information

Combination therapy can reduce chance of recurrence from small HER2+ breast tumors

Women with stage 1 HER2-positive breast tumors who received a combination of lower-intensity chemotherapy and a targeted drug following surgery were unlikely to suffer cancer recurrence within 3 years of treatment.

Stereotactic body radiation therapy (SBRT) plus chemotherapy improves survival among patients with stage 4 lung cancer

Combining stereotactic body radiation therapy (SBRT) with a specific chemotherapy regimen more than doubled survival rates for certain patients with stage 4 lung cancer, according to recent research data.

Comparison of medications for managing anxiety

Comparison of medications for managing anxiety

Is a comparison guide for common medications used for side-effect management, such as constipation, nausea, anxiety, etc. that includes a cost comparison available?

Second-line ramucirumab delays disease progression in advanced colorectal cancer

A combination treatment with of the drug ramucirumab and FOLFIRI chemotherapy provides a survival advantage over standard treatment with FOLFIRI alone for patients with advanced colorectal cancer, according to study data.

Long-term outcomes improved by combining bevacizumab with newer chemotherapy regimen for advanced colorectal cancer

A phase III study of patients with metastatic colorectal cancer has indicated that FOLFOXIRI chemotherapy, in combination with bevacizumab, is superior to the standard FOLFIRI chemotherapy with bevacizumab.

Therapy dogs benefit adult patients with cancer receiving chemo, radiation

Therapy dogs benefit adult patients with cancer receiving chemo, radiation

Therapy dogs improve the emotional well-being of some patients with cancer who are undergoing concomitant chemotherapy and radiotherapy.

Effectiveness of drugs to prevent hepatitis among patients receiving chemotherapy

Use of the antiviral drug entecavir resulted in a lower incidence of hepatitis B virus (HBV)-related hepatitis and HBV reactivation among patients with lymphoma undergoing a certain type of chemotherapy.

PRM-151 therapy well tolerated by patients with advanced myelofibrosis

PRM-151 therapy well tolerated by patients with advanced myelofibrosis

The compound PRM-151 (PRM) has shown success in reducing progressive bone marrow fibrosis in patients with advanced myelofibrosis.

Positive study data could improve standard of care for Hodgkin lymphoma

Patients with Hodgkin lymphoma who received brentuximab vedotin after transplantation lived longer without disease progression than patients who received only supportive care, per clinical trial data.

Managing oral side effects of irinotecan therapy

Managing oral side effects of irinotecan therapy

Is there an effective way to manage the oral side effects of irinotecan therapy?

Stat Consult Slideshows

Fluorouracil (5-FU)

This slideshow reviews fluorouracil (5-FU), indicated for palliative treatment of breast cancer, colorectal cancer, gastric cancer, and carcinoma of the pancreas; also adjuvant treatment of colorectal cancer.

Netupitant/Palonosetron (Akynzeo)

This slideshow reviews netupitant/palonosetron (Akynzeo), indicated for prevention of acute and delayed nausea and vomiting associated with initial and repeat courses of cancer chemotherapy.

Bevacizumab (Avastin)

This slideshow reviews bevacizumab (Avastin), indicated for cervical cancer, in combination with paclitaxel and cisplatin or paclitaxel and topotecan in persistent, recurrent, or metastatic disease.

To view all content in our Stat Consult section, please click here.

Sign Up for Free e-newsletters

Regimen and Drug Listings


Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Genitourinary Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Rare Cancers Regimens
Skin Cancer Regimens Drugs